【24h】

A selective HPLC method for determination of lercanidipine in tablets.

机译:选择性HPLC法测定片剂中的lercanidipine

获取原文
获取原文并翻译 | 示例
           

摘要

An HPLC reversed phase method using both UV (356 nm) and electrochemical (1000 mV) detection was developed in order to determine lercanidipine in commercial tablets. Repeatability and reproducibility were adequate. For quantification we have used the calibration plot method for lercanidipine concentration ranging between 1 x 10(-5) and 1 x 10(-4) M. Also, the proposed method is sufficiently selective to distinguish the parent drug and the degradation products after hydrolysis, photolysis or chemical oxidation. Furthermore, the typical excipients included in the drug formulation (talc, lactose, cornstarch, microcrystalline cellulose, carboxymethylcellulose and magnesium stearate) do not interfere with the selectivity of the method. Finally, the proposed chromatographic method was successfully applied to the quantitative determination of lercanidipine in commercial tablets.
机译:为了测定市售片剂中的乐卡地平,开发了一种使用UV(356 nm)和电化学(1000 mV)检测的HPLC反相方法。重复性和再现性足够。为了进行定量,我们使用了勒卡地平浓度范围为1 x 10(-5)和1 x 10(-4)M的校准图方法。此外,该方法具有足够的选择性以区分母体药物和水解后的降解产物,光解或化学氧化。此外,药物制剂中包括的典型赋形剂(滑石粉,乳糖,玉米淀粉,微晶纤维素,羧甲基纤维素和硬脂酸镁)不会干扰该方法的选择性。最终,所提出的色谱方法成功地用于商业片剂中乐卡地平的定量测定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号